Our products are similar to private equity than bank financing, with terms appropriate for gazelles, including risk-sharing, performance-based features. Given our higher risk profile, we also expect higher returns.
Repayment schedule tailored to the
projected
cash flows of the company, and flexible overall term (but
typically 5 years)
Lower collateral requirements than banks
Fixed interest rate comparable to the prevailing market rate
As a premium for risk, participation in a percentage of the company’s income for the term of the
loan
USD denomination
Minority equity stake in the company (typically up to 35%).
Pre-agreed share buy-back terms with price typically based on a formula tied to the revenue
performance of the company or other growth metric.
Patient capital with a pre-agreed buy back that typically takes place in stages over years 3-5
(with
full exit in year 5).
Unlike traditional private equity, we do not force the sale of your company to a 3rd party.
Our financing and partnership-oriented approach enables entrepreneurs to take their businesses
through
the next stage of revenue growth and achieve their full potential.